PMID- 2646702 OWN - NLM STAT- MEDLINE DCOM- 19890420 LR - 20190903 IS - 0036-5599 (Print) IS - 0036-5599 (Linking) VI - 23 IP - 1 DP - 1989 TI - Prospective management of neonates with pelviureteric junction stenosis. Therapeutic strategy based on 99m Tc-DPTA studies. PG - 31-6 AB - A prospective therapeutic strategy based on separate glomerular filtration rate (SGFR) was evaluated in 14 prenatally detected asymptomatic neonates, suspected of having pelviureteric junction obstruction. The patients with low SGFR were referred for pyeloplasty with the hope to improve the renal function. A marked improvement occurred in only one patient, although the drainage function (furosemide test) did improve in all cases. A conservative attitude was adopted for those children with normal SGFR. In 6 of them, a progressive increase of SGFR was noted, related to the normal maturation of the function, followed by a stabilization in the normal range. In 1 patient, a sudden decrease of SGFR was observed around 1 year and the patient was shifted into the surgical group. In this patient, an initial partial response of the kidney to a furosemide injection changed into a persistent non-response, whereas in the other non-operated patients, partial or good response was always recorded, although the responses were essentially variable on successive tests. On the basis of these data, the protocol was slightly modified, the patients with persistent non-response to furosemide after 6 months of life being shifted to the surgical group. FAU - Piepsz, A AU - Piepsz A AD - Department of Radioisotopes, Free Universities of Brussels, Belgium. FAU - Hall, M AU - Hall M FAU - Ham, H R AU - Ham HR FAU - Verboven, M AU - Verboven M FAU - Collier, F AU - Collier F LA - eng PT - Comparative Study PT - Journal Article PL - England TA - Scand J Urol Nephrol JT - Scandinavian journal of urology and nephrology JID - 0114501 RN - 0 (Organometallic Compounds) RN - 7440-26-8 (Technetium) RN - 7A314HQM0I (Pentetic Acid) RN - 7LXU5N7ZO5 (Furosemide) RN - VW78417PU1 (Technetium Tc 99m Pentetate) SB - IM MH - Clinical Protocols MH - Follow-Up Studies MH - Furosemide MH - Glomerular Filtration Rate MH - Humans MH - Infant, Newborn MH - Kidney/*diagnostic imaging MH - Kidney Pelvis/surgery MH - *Organometallic Compounds MH - *Pentetic Acid MH - Prenatal Diagnosis MH - Prospective Studies MH - Radioisotope Renography MH - *Technetium MH - Technetium Tc 99m Pentetate MH - Ureteral Obstruction/diagnostic imaging/*therapy EDAT- 1989/01/01 00:00 MHDA- 1989/01/01 00:01 CRDT- 1989/01/01 00:00 PHST- 1989/01/01 00:00 [pubmed] PHST- 1989/01/01 00:01 [medline] PHST- 1989/01/01 00:00 [entrez] AID - 10.1080/00365599.1989.11690428 [doi] PST - ppublish SO - Scand J Urol Nephrol. 1989;23(1):31-6. doi: 10.1080/00365599.1989.11690428.